DK1227103T3 - Nukleosider og nukleotider med forstörrede ringe - Google Patents

Nukleosider og nukleotider med forstörrede ringe

Info

Publication number: DK1227103T3
Authority: DK; Denmark
Prior art keywords: compositions; nucleosides; nucleotides; purine; ring
Prior art date: 1993-09-29

Application number

DK02001587T

Other languages

Danish (da)

English (en)

Inventor

Barry Burns

Ramachandra Hosmane

Original Assignee

Univ Maryland

Nabi

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-09-29

Filing date

1994-09-29

Publication date

2006-11-27

1994-09-29 Application filed by Univ Maryland, Nabi filed Critical Univ Maryland

2006-11-27 Application granted granted Critical

2006-11-27 Publication of DK1227103T3 publication Critical patent/DK1227103T3/da

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/052—Imidazole radicals

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Communicable Diseases (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Oncology (AREA)
Molecular Biology (AREA)
Virology (AREA)
Tropical Medicine & Parasitology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)

DK02001587T 1993-09-29 1994-09-29 Nukleosider og nukleotider med forstörrede ringe DK1227103T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US12821293A	1993-09-29	1993-09-29
EP94929358A EP0724587B8 (en)	1993-09-29	1994-09-29	Ring-expanded nucleosides and nucleotides

Publications (1)

Publication Number	Publication Date
DK1227103T3 true DK1227103T3 (da)	2006-11-27

Family

ID=22434211

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK02001587T DK1227103T3 (da)	1993-09-29	1994-09-29	Nukleosider og nukleotider med forstörrede ringe
DK94929358T DK0724587T3 (da)	1993-09-29	1994-09-29	Nukleosider og nukleotider med forstørrede ringe

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DK94929358T DK0724587T3 (da)	1993-09-29	1994-09-29	Nukleosider og nukleotider med forstørrede ringe

Country Status (9)

Country	Link
EP (2)	EP0724587B8 (pt)
AT (2)	ATE223428T1 (pt)
AU (1)	AU7844594A (pt)
CA (1)	CA2173116C (pt)
DE (2)	DE69434805T2 (pt)
DK (2)	DK1227103T3 (pt)
ES (2)	ES2269528T3 (pt)
PT (2)	PT1227103E (pt)
WO (1)	WO1995009175A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7094766B1 (en)	1995-06-06	2006-08-22	Trustees Of Boston University	Use of locally applied DNA fragments
US6147056A (en) *	1995-06-06	2000-11-14	Trustees Of Boston University	Use of locally applied DNA fragments
US5955059A (en) *	1995-06-06	1999-09-21	Trustees Of Boston University	Use of locally applied DNA fragments
US20030032610A1 (en)	1996-06-03	2003-02-13	Gilchrest Barbara A.	Method to inhibit cell growth using oligonucleotides
AU2001251115A1 (en)	2000-03-31	2001-10-15	Trustees Of Boston University	Use of locally applied dna fragments
US6555581B1 (en)	2001-02-15	2003-04-29	Jones Pharma, Inc.	Levothyroxine compositions and methods
FR2825705B1 (fr)	2001-06-08	2005-05-20	Aventis Pharma Sa	Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens
FR2835186B1 (fr)	2002-01-28	2006-10-20	Aventis Pharma Sa	Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases
FR2844273B1 (fr)	2002-09-05	2008-04-04	Aventis Pharma Sa	Nouveaux composes heterocycliques, procede et intermediaires de preparation et utilisation comme medicament, notamment comme inhibiteurs de beta-lactamases et anti-bacteriens.
CN107074904B (zh)	2014-10-23	2022-12-23	深圳华大智造科技股份有限公司	信号约束测序(scs)和用于信号约束测序的核苷酸类似物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS60992B2 (ja) *	1977-03-15	1985-01-11	財団法人微生物化学研究会	コホルマイシンおよび関連物質の分離法
US4163839A (en) *	1977-12-09	1979-08-07	Zaidan Hojin Biselbutsu Kagaku Kenkyu Kai	Isocoformycin and a process for the production thereof
US4935505A (en) *	1983-05-03	1990-06-19	Townsend Leroy B	Novel azolo [1,3] diazepine-5-ol compounds and their uses
US4713372A (en) *	1984-03-16	1987-12-15	Warner-Lambert Company	2-chloropentostatin compound having adenosine diaminase inhibitory activity
IL108524A0 (en) *	1993-02-03	1994-05-30	Gensia Inc	Imidazodiazepine analogs

1994
- 1994-09-29 EP EP94929358A patent/EP0724587B8/en not_active Expired - Lifetime
- 1994-09-29 DE DE69434805T patent/DE69434805T2/de not_active Expired - Lifetime
- 1994-09-29 AT AT94929358T patent/ATE223428T1/de not_active IP Right Cessation
- 1994-09-29 DK DK02001587T patent/DK1227103T3/da active
- 1994-09-29 AU AU78445/94A patent/AU7844594A/en not_active Abandoned
- 1994-09-29 PT PT02001587T patent/PT1227103E/pt unknown
- 1994-09-29 DE DE69431304T patent/DE69431304T2/de not_active Expired - Lifetime
- 1994-09-29 ES ES02001587T patent/ES2269528T3/es not_active Expired - Lifetime
- 1994-09-29 AT AT02001587T patent/ATE334137T1/de not_active IP Right Cessation
- 1994-09-29 PT PT94929358T patent/PT724587E/pt unknown
- 1994-09-29 ES ES94929358T patent/ES2182847T3/es not_active Expired - Lifetime
- 1994-09-29 DK DK94929358T patent/DK0724587T3/da active
- 1994-09-29 WO PCT/US1994/010905 patent/WO1995009175A1/en active IP Right Grant
- 1994-09-29 CA CA002173116A patent/CA2173116C/en not_active Expired - Fee Related
- 1994-09-29 EP EP02001587A patent/EP1227103B1/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
WO1995009175A1 (en)	1995-04-06
ES2269528T3 (es)	2007-04-01
DE69434805D1 (de)	2006-09-07
ATE223428T1 (de)	2002-09-15
PT1227103E (pt)	2006-12-29
EP1227103A2 (en)	2002-07-31
EP0724587A4 (en)	1996-12-27
EP0724587B8 (en)	2003-01-29
DE69431304D1 (de)	2002-10-10
EP1227103A3 (en)	2002-10-16
DE69434805T2 (de)	2007-02-22
DE69431304T2 (de)	2003-05-15
ES2182847T3 (es)	2003-03-16
CA2173116A1 (en)	1995-04-06
ATE334137T1 (de)	2006-08-15
EP0724587B1 (en)	2002-09-04
CA2173116C (en)	2006-02-28
PT724587E (pt)	2003-01-31
EP1227103B1 (en)	2006-07-26
AU7844594A (en)	1995-04-18
DK0724587T3 (da)	2003-01-06
EP0724587A1 (en)	1996-08-07

Similar Documents

Publication	Publication Date	Title
MD1224B2 (en)	1999-05-31	Application of nucleoside analogues with 1,3-oxathiolan for treatment of hepatitis B
IL101836A0 (en)	1992-12-30	Pharmaceutical compositions containing 1,3-oxathiolane nucleoside derivatives
TW366347B (en)	1999-08-11	Antiviral pharmaceutical compositions comprising 1,3-oxathiolane nucleoside analogues
IL101144A0 (en)	1992-11-15	Pharmaceutical compositions containing 1,3-oxathiolane nucleoside analogue and derivatives thereof for the treatment of hepatitis b virus infections
RU93043875A (ru)	1997-02-20	1-(2-гидроксиметил)-1,3-оксатиолан-5-ил)-5-фторцитозин и способ лечения
MD1838G2 (ro)	2002-08-31	Derivaţi de 5,6-diclorbenzimidazol, procedeu de obţinere a lor, compoziţie farmaceutică şi metodă de tratament sau de prevenire a infecţiei virotice herpetice
AU591125B2 (en)	1989-11-30	Therapeutic nucleosides
ES2138969T3 (es)	2000-02-01	Combinacion de nucleosidos antivirales.
MY127808A (en)	2006-12-29	Use of dideoxy nucleoside analogues in the treatment of viral infections
DK1227103T3 (da)	2006-11-27	Nukleosider og nukleotider med forstörrede ringe
MY105523A (en)	1994-10-31	Substituted-1,3-oxathiolanes with antiviral properties.
ES2125976T3 (es)	1999-03-16	Otros derivados de indol con accion antiviral.
KR910007655A (ko)	1991-05-30	치료용 뉴클레오시드
MY126450A (en)	2006-10-31	Crystalline efavirenz
IE893080L (en)	1990-03-27	Novel 2'-halomethylidene,2'-ethenylidene and¹2'-ethynyl adenosine derivatives
MX9701273A (es)	1997-05-31	Succinato de (4-(2-amino-6-(ciclopropilamino)-9h-purin-9-il)2-ciclopenten-1-metanol como agente antiviral.
WO1990013281A3 (en)	2004-04-22	Method of suppressing hiv infection
DK1115420T3 (da)	2002-11-04	Behandling af hepatitis B med thymosin-alpha-1 og lamivudin
PT87004A (pt)	1988-04-01	Process for the preparation of compositions for the treatment of viral infections and composites 3'-azide-2',3'-didesoxy-in osine and 3'-fluoro-2',3'-didesoxyguanosine
MY137298A (en)	2009-01-30	Therapeutic nucleosides
DK0393530T3 (da)	1995-05-22	5,11-Dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-oner og -thioner og deres anvendelse til forebyggelse eller behandling af AIDS
IL92402A0 (en)	1990-07-26	Pyrimidine nucleoside derivatives,their preparation and pharmaceutical compositions containing them
GR3017335T3 (en)	1995-12-31	Oligophosphates with antiviral activity.
DE3854158D1 (de)	1995-08-17	Nucleosid-analoge.
MY113560A (en)	2002-04-30	Use of 5-fluoro-2'-deoxy-3'-thiacytidine for the treatment of hepatitis b